Intellectual Property

Arog Pharmaceuticals, Inc. maintains a robust patent portfolio featuring world-wide protection for Crenolanib beyond 2030 in major markets. Further information regarding Arog's intellectual property assets can be made only under CDA. Contact us to request additional information regarding Arog's intellectual property assests.